Healthpeak Properties: The Market Still Underestimates Its Recovery Potential

IWA Research 3.34K Followers Follow Summary Healthpeak Properties remains a Buy, supported by strong earnings, attractive dividend, and an ongoing portfolio pivot despite macro headwinds. DOC delivered a robust Q2, beating FFO and revenue estimates, increasing guidance, and executing $1 billion in asset sales to strengthen liquidity. Valuation remains compelling, with intrinsic value estimated above current levels even under conservative estimates, supported by conservative AFFO growth and a high discount rate. Macro risks persist, but tightening supply and sector dealmaking position DOC for long-term re-rating as market conditions improve. Tom Werner/DigitalVision via Getty Images Introduction Back when I last covered Healthpeak Properties ( DOC ), I rated it a Buy, arguing how the valuation still offered room for upside despite its rally seen at that time, supported by strong earnings, an This article was written by IWA Research 3.34K Followers Follow I've been researching companies in-depth for over a decade, from commodities like oil, natural gas, gold and copper to tech like Google or Nokia and many emerging market stocks, which I believe could help me provide useful content for readers. After writing my own blog for about 3 years, I decided to switch to a value investing-focused YouTube channel, where I researched hundreds of different companies so far. I would say my favorite type of company to cover are metals and mining stocks, but I am comfortable with several other industries, such as consumer discretionary/staples, REITs and utilities. Analyst’s Disclosure: I/we have a beneficial long position in the shares of DOC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.